Boston‑based scientists announced Wednesday that they have identified biological factors that could explain why colorectal cancer often behaves more aggressively in patients diagnosed before age 50. The findings, published in Nature Medicine, stem from an analysis of 189 tumor samples, including 54 from younger patients.
Key cellular differences
The research team measured gene activity in hundreds of thousands of individual cells. They discovered that tumors from younger individuals contained a significantly higher proportion of connective and supporting cells compared with cancer cells. In other cancer types, a greater share of these supportive cells has been linked to resistance against chemotherapy.
Enhanced cell‑to‑cell signaling
In addition to the cellular composition, the scientists observed stronger signaling pathways between cells in the younger‑patient tumors. Such signaling can facilitate the cancer’s ability to infiltrate nearby tissue, potentially leading to faster disease progression.
RNA activity differences
The study also highlighted differences in RNA expression. Younger patients showed higher activity of long non‑coding RNAs—molecules that regulate genes without producing proteins. Some of these RNAs appeared repeatedly across various cancer cell types, while many remain “dark” RNAs whose functions are still largely unknown.
Implications and next steps
Although the researchers describe their work as providing “key insight,” they caution that the findings do not yet prove a direct causal link between these cellular and molecular patterns and the more aggressive disease course seen in younger patients. Dr. Ramnik J. Xavier, one of the lead investigators, said the study sets the stage for future mechanistic research on how diet, gut microbes, and these cellular programs interact to cause early‑onset colorectal cancer.
Understanding these differences could eventually lead to more targeted therapies for younger patients, who historically have faced poorer outcomes with standard chemotherapy regimens. The team hopes that further investigation will translate these biological clues into clinical strategies that improve survival and quality of life.
Original reporting: WESH Orlando — read the source article.
